The Retinal Biologics Market is experiencing a surge in demand, fueled by advancements in eye disease treatments and a growing emphasis on vision health. According to a recent analysis by Future Market Insights (FMI), a leading market research firm, the market is currently valued at an impressive US$22.25 billion in 2022. Looking ahead, the market …
Tag Archives: Retinal Biologics
Global Retinal Biologics Industry Eyes an Impressive US$41.92 Billion Valuation by 2028, Fueled by Solid 11.1% CAGR | FMI Insights Reveals
The Global Retinal Biologics Industry is on the brink of a transformative journey, exhibiting remarkable growth with a projected value exceeding US$22.25 billion by 2022. This upward trajectory is set to surge even further, reaching a staggering US$41.92 billion by 2028, propelled by an impressive Compound Annual Growth Rate (CAGR) of 11.1% between 2022 and …
Global Retinal Biologics Industry Poised for an Impressive US$41.92 Billion Valuation by 2028, Driven by a Resilient 11.1% CAGR | According to FMI Insights
The Global Retinal Biologics Industry is undergoing a spectacular transformation, showcasing robust growth with an anticipated value exceeding US$22.25 billion by 2022. This upward trajectory is expected to continue, reaching a staggering US$41.92 billion by 2028, driven by an impressive Compound Annual Growth Rate (CAGR) of 11.1% between 2022 and 2028, according to recent insights …
Global Retinal Biologics Industry Poised for US$41.92 Billion by 2028, Growing at 11.1% CAGR | FMI Insights
The Global Retinal Biologics Industry is experiencing remarkable growth, with an anticipated value of more than US$ 22.25 billion by 2022, set to further expand to US$ 41.92 billion by 2028, marking an impressive 11.1% Compound Annual Growth Rate (CAGR) between 2022 and 2028. Key Market Insights: Rising Prevalence of Diabetes-related Eye Disorders and Age-related …